Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MUM | MUM relisting tomorrow as IHL | 02/08/17 | 1 | 2.4K | |||
|
|||||||
MUM | Ann: Alistiar Pty Ltd becomes a Substantial Holder-MUM.AX | 28/10/16 | 0 | 971 | |||
|
|||||||
MUM | Ann: Appendix 3B-MUM.AX | 21/10/16 | 0 | 837 | |||
|
|||||||
MUM | Ann: Final Directors Interest Notice - Fennell-MUM.AX | 21/10/16 | 0 | 806 | |||
|
|||||||
MUM | Ann: Final Directors Interest Notice - Leavy-MUM.AX | 21/10/16 | 0 | 786 | |||
|
|||||||
MUM | Ann: Initial Directors Interest Notice - Weston-MUM.AX | 21/10/16 | 0 | 738 | |||
|
|||||||
MUM | Ann: Initial Directors Interest Notice - Smith-MUM.AX | 21/10/16 | 0 | 922 | |||
|
|||||||
MUM | Ann: Initial Directors Interest Notice - Worsfold-MUM.AX | 21/10/16 | 0 | 658 | |||
|
See All Discussions